Safak Yalcin
Therapeutics Clinical Research(US)Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
FOXO transcription factor regulation, MicroRNA in disease regulation, Epigenetics and DNA Methylation, Immune Cell Function and Interaction, Phagocytosis and Immune Regulation
Most-Cited Works
- → Foxo3 is required for the regulation of oxidative stress in erythropoiesis(2007)313 cited
- → FOXO1 is an essential regulator of pluripotency in human embryonic stem cells(2011)266 cited
- → Foxo3 Is Essential for the Regulation of Ataxia Telangiectasia Mutated and Oxidative Stress-mediated Homeostasis of Hematopoietic Stem Cells(2008)244 cited
- → ROS‐mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3−/− mice(2010)141 cited
- → FOXO3‐mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis(2014)94 cited
- → Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia(2015)77 cited
- → Prevalence of Human Herpesvirus 6 Variants A and B in Patients with Chronic Fatigue Syndrome(1994)51 cited
- → Stra13 regulates oxidative stress mediated skeletal muscle degeneration(2009)42 cited
- → Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells(2016)38 cited
- → Regulation and Function of FoxO Transcription Factors in Normal and Cancer Stem Cells: What Have We Learned?(2011)38 cited